These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2024232)

  • 1. Antithrombotic effects of the association standard heparin-dermatan sulfate.
    Caranobe C; Gabaig AM; Sié P; Boneu B
    Thromb Haemost; 1991 Jan; 65(1):107. PubMed ID: 2024232
    [No Abstract]   [Full Text] [Related]  

  • 2. Standard heparin enhances the antithrombotic activity of dermatan sulfate in the rabbit but CY 216 does not.
    Cadroy Y; Dol F; Caranobe C; Petitou M; Lormeau JC; Sié P; Choay J; Boneu B
    Thromb Haemost; 1988 Apr; 59(2):295-8. PubMed ID: 2838927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rationale for targeting antithrombotic therapy at the vessel wall: improved antithrombotic effect and decreased risk of bleeding.
    Buchanan MR; Brister SJ
    Wien Klin Wochenschr; 1999 Feb; 111(3):81-9. PubMed ID: 10093889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey of the clinical experience with dermatan sulfate.
    Gianese F; Lucchelli PE
    Semin Thromb Hemost; 1991; 17 Suppl 2():199-204. PubMed ID: 1948090
    [No Abstract]   [Full Text] [Related]  

  • 5. Potentiation of the antithrombotic action of dermatan sulphate by small amounts of heparin.
    Thomas DP; Gray E; Merton RE
    Thromb Haemost; 1990 Oct; 64(2):290-3. PubMed ID: 2270536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermatan sulphate for the prevention of postoperative venous thromboembolism in patients with cancer. DOS (Dermatan sulphate in Oncologic Surgery) Study Group.
    Di Carlo V; Agnelli G; Prandoni P; Coccheri S; Gensini GF; Gianese F; Mannucci PM
    Thromb Haemost; 1999 Jul; 82(1):30-4. PubMed ID: 10456450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with a new antithrombotic (dermatan sulfate) in chronic hemodialysis patients.
    Nurmohamed MT; Knipscheer HC; Stevens P; Krediet RT; Roggekamp MC; Berckmans RJ; ten Cate JW
    Clin Nephrol; 1993 Mar; 39(3):166-71. PubMed ID: 8462205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic activity of dermatan sulphates, heparins and their combination in an animal model of arterial thrombosis.
    Iacoviello L; D'Adamo MC; Pawlak K; Polishchuck R; Wollny T; Buczko W; Donati MB
    Thromb Haemost; 1996 Dec; 76(6):1102-7. PubMed ID: 8972038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental studies on the relative efficacy of dermatan sulphate and heparin as antithrombotic agents.
    Merton RE; Thomas DP
    Thromb Haemost; 1987 Oct; 58(3):839-42. PubMed ID: 3433248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic and anticomplementary properties of a very low molecular mass dermatan sulfate.
    Fabiana Alberto M; Giaquinta Romero D; Lazzari M; Calabrese GC
    Thromb Res; 2008; 122(1):109-16. PubMed ID: 17936880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic activity of Desmin 370. Comparison with a high molecular weight dermatan sulfate.
    Barbanti M; Calanni F; Babbini M; Bergonzini G; Parma B; Marchi E; Wassermann A
    Thromb Res; 1993 Sep; 71(5):417-22. PubMed ID: 8236168
    [No Abstract]   [Full Text] [Related]  

  • 12. One-dimensional cellulose acetate plate electrophoresis--a feasible method for analysis of dermatan sulfate and other glycosaminoglycan impurities in pharmaceutical heparin.
    Domanig R; Jöbstl W; Gruber S; Freudemann T
    J Pharm Biomed Anal; 2009 Jan; 49(1):151-5. PubMed ID: 19062213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unbalanced effects of dermatan sulfates with different sulfation patterns on coagulation, thrombosis and bleeding.
    Vicente CP; Zancan P; Peixoto LL; Alves-Sá R; Araújo FS; Mourão PA; Pavão MS
    Thromb Haemost; 2001 Nov; 86(5):1215-20. PubMed ID: 11816710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombin activity and disaccharide composition of dermatan sulfate from different bovine tissues.
    Osborne SA; Daniel RA; Desilva K; Seymour RB
    Glycobiology; 2008 Mar; 18(3):225-34. PubMed ID: 18156656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatan sulfate as a potential antithrombotic drug.
    Pangrazzi J; Gianese F
    Haematologica; 1987; 72(5):459-64. PubMed ID: 3121470
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of dermatan sulfate and heparan sulfate on platelet activity compared to heparin.
    Hoppensteadt DA; Walenga JM; Fareed J
    Semin Thromb Hemost; 1991; 17 Suppl 1():60-4. PubMed ID: 2068572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new animal model of coronary thrombosis and effects of antithrombotic agents.
    Zhang W; Wang P; Chen Z; Fan Y
    Chin Med J (Engl); 1995 May; 108(5):370-2. PubMed ID: 7555240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined antithrombotic therapy for acute coronary syndrome.
    Gawaz M; Müller I; Besta F
    Semin Vasc Med; 2003 May; 3(2):163-76. PubMed ID: 15199479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dermatan sulfate and the prevention of experimental venous thrombosis].
    Desnoyers P; Bara L; Samama M
    Pathol Biol (Paris); 1989 Jun; 37(6):759-67. PubMed ID: 2674877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatan sulphate in haemodialysis.
    Lane DA; Ryan K; Ireland H; Curtis JR; Nurmohamed MT; Krediet RT; Roggekamp MC; Stevens P; ten Cate JW
    Lancet; 1992 Feb; 339(8789):334-5. PubMed ID: 1346414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.